The abstract is read at the publisher; the summary is JClub's.
Innate immune triggers induce IRG1 expression, driving itaconate accumulation that promotes IRG1-dependent PANoptosis, with glutaminolysis fueling the pathway.
- Why it matters: PANoptosis must be tightly regulated to avoid excessive inflammation, but the metabolic mechanisms that connect innate signaling to inflammatory cell death are not well defined.
- What they did: The study mapped an IRG1–itaconate axis in response to innate immune triggers, tested glutamine metabolism’s role in itaconate production, and used NAD depletion to assess upstream control of NLRC5-PANoptosome assembly.
- The result: Glutamine metabolism inhibition reduced itaconate accumulation and blocked PANoptosis, while NAD depletion induced IRG1 and promoted NLRC5-PANoptosome assembly, suggesting IRG1 as a therapeutic target in hemolytic and inflammatory diseases.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.